SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- President Donald J. Trump is expected to deliver his take on prescription drugs in America and the anticipation for the said event increases by the day. No one seems to forget how he lamented about the continuous rise of the cost of drugs during his presidential campaign back in 2012.
Studies suggest that the American households are significantly affected by the drug prices’ increase. The average yearly cost of drugs prescribed among seniors was $6,425 in 2012 and then increased to a staggering amount of $12,951 in 2017. The president blasted pharmaceutical companies and other countries how they monopolize the industry leaving little room for competitive pricing for the benefit of the consumers who are struggling with heroin addiction.
The US Food and Drug Administration approved the production and sale of generic drugs in the country quicker than expected as the president was putting pressure on the agency. The move injected more competition as well as provided a cheaper alternative to consumers who cannot afford branded prescribed drugs. From the time he was campaigning to date, people are speculating on what he is going to say, and it is creating a public apprehension regarding this pressing issue.
Many believe that drug prices are supposed to be Washington’s priority, and legislation should be passed to address this issue. The Trump administration even scrutinizes the lower cost of drugs in other countries. Analysts have varying views on the impact of the government's proposals on the matter, but everything is put on hold until the president delivers his speech. As the much-awaited speech on prescription drugs in America is drawing near, both the president’s supporters and critics are expected to listen as to what he has to say.
You can get more information at https://www.therecover.com. For queries, the line is open for calls at (888) 510-3898
Contact:
Company: The Recover
Address: Temecula CA
Contact Number: (888) 510-3898
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/852de27a-43c9-4fb2-85d8-0fe324febefe